Skip Nav Destination
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis
Issue Archive
August 1 2001
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers
Susann Szmania,Amanda Galloway,Mary Bruorton,Philip Musk,Geraldine Aubert,Andrew Arthur,Haywood Pyle,Nancy Hensel,Nga Ta,Lawrence Lamb, Jr,Toni Dodi,Alejandro Madrigal,John Barrett,Jean Henslee-Downey,Frits van Rhee
CHEMOKINES
Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells
Paolo Ghia,Pietro Transidico,J. Pedro Veiga,Christoph Schaniel,Federica Sallusto,Kouji Matsushima,Stephen E. Sallan,Antonius G. Rolink,Alberto Mantovani,Lee M. Nadler,Angelo A. Cardoso
HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway
Dorothée Missé,Pierre-Olivier Esteve,Benoit Renneboog,Michel Vidal,Martine Cerutti,Yves St Pierre,Hans Yssel,Marc Parmentier,Francisco Veas
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
Clinical Trials & Observations
Richard M. Stone,Deborah T. Berg,Stephen L. George,Richard K. Dodge,Paolo A. Paciucci,Philip P. Schulman,Edward J. Lee,Joseph O. Moore,Bayard L. Powell,Maria R. Baer,Clara D. Bloomfield,Charles A. Schiffer
Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study
Clinical Trials & Observations
Donald Bunjes,Inga Buchmann,Christian Duncker,Ulrike Seitz,Jörg Kotzerke,Markus Wiesneth,Dagmar Dohr,Martin Stefanic,Andreas Buck,Stefanie V. Harsdorf,Gerhard Glatting,Wolfgang Grimminger,Tunca Karakas,Gerd Munzert,Hartmut Döhner,Lothar Bergmann,Sven N. Reske
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
Clinical Trials & Observations
Luis F. Porrata,Morie A. Gertz,David J. Inwards,Mark R. Litzow,Martha Q. Lacy,Ayalew Tefferi,Dennis A. Gastineau,Angela Dispenzieri,Stephen M. Ansell,Ivana N. M. Micallef,Susan M. Geyer,Svetomir N. Markovic
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis
Clinical Trials & Observations
Jeanne E. Anderson,Ayalew Tefferi,Fiona Craig,Leona Holmberg,Thomas Chauncey,Frederick R. Appelbaum,Philippe Guardiola,Natalie Callander,Cesar Freytes,Yair Gazitt,Betty Razvillas,H. Joachim Deeg
GENE THERAPY
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibα
Nancy Cauwenberghs,Karen Vanhoorelbeke,Stephan Vauterin,Douwe F. Westra,Gabriel Romo,Eric G. Huizinga,José A. Lopez,Michael C. Berndt,Jolàn Harsfalvi,Hans Deckmyn
Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease
M. Said Enayat,Andrea M. Guilliatt,Gurcharan K. Surdhar,P. Vincent Jenkins,K. John Pasi,Cheng Hock Toh,Michael D. Williams,Frank G. H. Hill
IMMUNOBIOLOGY
NEOPLASIA
HTLV-1 p12I protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells
Christophe Nicot,James C. Mulloy,Maria G. Ferrari,Julie M. Johnson,Kaisong Fu,Risaku Fukumoto,Raffaella Trovato,Jake Fullen,Warren J. Leonard,Genoveffa Franchini
PHAGOCYTES
RED CELLS
TRANSPLANTATION
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD
Yuji Miura,Christopher J. Thoburn,Emilie C. Bright,Matthias Sommer,Susan Lefell,Mikio Ueda,Shinji Nakao,Allan D. Hess
BRIEF REPORTS
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals